MLTX Overview
Upcoming Projects (MLTX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (MLTX)
-
Discussing the upcoming phase 3 readout of povorcitinib in Hidradenitis Suppurativa, as well as other investigational agents including upadacitinib and sonelokimab
Tickers: INCY, ABBV, MLTX
Executed On: Jan 30, 2025 at 10:00 AM EST -
Delving into the phase 2 ARGO clinical trial data presented at ACR 50 on Moonlake Therapeutics' Nanobody (sonelokimab) for treating active psoriatic arthritis.
Ticker: MLTX
Executed On: Nov 30, 2023 at 04:30 PM EST -
Examining the potential of Moonlake Therapeutics' sonelokimab in treating hidradenitis suppurativa (HS) with a focus on the recent Phase 2 MIRA data
Ticker: MLTX
Executed On: Jul 27, 2023 at 09:05 AM EDT
Upcoming & Overdue Catalysts (MLTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (MLTX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
